Goodwin Procter (Washington, DC)
STEPHANIE PHILBIN is counsel at Goodwin and Procter LLP in the FDA Group and is a member of the firm’s Life Sciences Practice. She joined Goodwin Procter in 2007 and concentrates on Food and Drug Administration laws. Ms. Philbin advises clients on regulatory and compliance issues including those related to the Quality System Regulation, Medical Device Reporting, recalls, product importing and exporting, product promotion, pre-market submissions and compliance. Ms. Philbin assists clients in responding to agency investigations and in filing comments with FDA to respond to various regulatory initiatives. She also reviews SEC filings of FDA-regulated companies and conducts due diligence of companies as part of mergers and acquisitions, and assists in litigation.